Literature DB >> 5104122

Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants.

A Rane, P K Lunde, B Jalling, S J Yaffe, F Sjöqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5104122     DOI： 10.1016/s0022-3476(71)80369-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  29 in total

1.  Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.

Authors:  P M Loughnan; A Greenwald; W W Purton; J V Aranda; G Watters; A H Neims
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

2.  Factors affecting drug-protein binding in the plasma of newborn infants.

Authors:  S Wallace
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

3.  Decreased drug binding in serum from patients with chronic hepatic disease.

Authors:  S Wallace; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 4.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

5.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

6.  Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Authors:  Kevin M Watt; Christoph P Hornik; Stephen J Balevic; Gratias Mundakel; C Michael Cotten; Barrie Harper; Daniel K Benjamin; Ravinder Anand; Matthew Laughon; P Brian Smith; Michael Cohen-Wolkowiez
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

7.  Treating epilepsy in the setting of medical comorbidities.

Authors:  Nivedita U Jerath; Dronacharya Lamichhane; Madhu Jasti; Vinusha Yarlagadda; Eduardo Zilli; Yara Nazzal; Mark Granner
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

Review 8.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 9.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

10.  Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.

Authors:  R Gugler; G Mueller
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.